
Number of publications published per year by Soccorsi, Fabrizio. (Source : PubMed)

Distribution of publications types for Soccorsi, Fabrizio. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial.
BMC Gastroenterol
2010;10

Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon alpha-2a and ribavirin: a multicentric study.
Liver Int.
2009;29;10
Liver cirrhosis and rhino-orbital mucormycosis, a possible but rare association: description of a clinical case and literature review.
Braz J Infect Dis
2009;13;4



Peginterferon alpha-2a and ribavirin versus peginterferon alpha-2a monotherapy in early virological responders and peginterferon alpha-2a and ribavirin versus peginterferon alpha-2a, ribavirin and amantadine triple therapy in early virological nonresponders: the SMIEC II trial in naïve patients with chronic hepatitis C.
Eur J Gastroenterol Hepatol
2008;20;7
Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label study.
Clin Ther
2008;30;2

Management of chronic hepatitis in drug addicts: a systematic review.
Clin Ter
2008;159;1
[ See timeline ] [ See all publications ]
means that Soccorsi, Fabrizio has 3 papers cited a least 3 times - methodology
Liver Unit San Camillo Forlanini Hospital, Rome, Italy.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.